Overview


According to FutureWise analysis, the market for Automated and Closed Cell Therapy is expected to grow with a CAGR of 22.89% over the forecast period 2024-2032, and reach a market value of US$ 5.75 billion by 2031.

Automated and closed-cell therapy is an innovative approach that combines advanced technologies with the principles of cellular therapy, aiming to revolutionize how to address various medical conditions. Automated cell therapy involves using automated systems to facilitate and enhance the process of cell manipulation, expansion, and modification. This means that instead of relying solely on manual labour, sophisticated machines, and robotics take on a substantial portion of the work. This improves the accuracy and efficiency of cell processing and allows for the scalability of these therapies, potentially making them more accessible to a broader patient population. Also, the 'closed-cell' aspect of this therapy is equally crucial. It refers to the containment of cell cultures within a controlled, sterile environment, limiting exposure to external contaminants. This represents a significant advancement in the field of medical treatment, especially in the field of personalized medicine and regenerative therapies.

Automated and closed cell therapy are categorized into two types: stem cell therapy and non-stem cell therapy. Stem cell therapy involves the usage of specialized cells with the capability to differentiate into different cell types within the body, promoting tissue regeneration and repair. This method holds tremendous promise for treating various conditions, from degenerative disorders to injuries. On the other hand, non-stem cell therapy focuses on using cells that have reached a more specialized state, often targeting specific tissues or functions. This type of therapy can be equally effective in addressing certain medical issues offering tailored solutions for patients. The automated and closed nature of these therapies ensures precise control and monitoring, optimizing treatment outcomes and minimizing potential risks.

FutureWise Market Research has published a report that provides an insightful analysis automated and closed cell therapy market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts automated and closed cell therapy market estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Thermo Fisher Scientific Inc.
  • Miltenyi Biotec GmbH
  • Sartorius AG
  • Lonza Group AG
  • Terumo BCT, Inc.
  • Fresenius SE & Co. KGaA
  • GE Healthcare
  • Pall Corporation
  • Asahi Kasei Corporation
  • Merck KGaA

Recent Developments in Automated And Closed Cell Therapy Market:

  • In May 2021, Terumo BCT announced the acquisition of GID Group, a leading provider of closed-system cell and gene therapy manufacturing solutions. This strategic move significantly bolstered Terumo BCT's position in the automated and closed cell therapy sector, further enhancing its capabilities in the booming field of regenerative medicine.

  • In October 2021, Miltenyi Biotec launched the CliniMACS Prodigy X, a fully automated cell and gene therapy manufacturing platform, marking a major milestone in the advancement of automated and closed cell therapy.

The increasing demand for advanced and automated technologies within the cell therapy market has been catalyzed by a growing need for precision and efficiency. Integrated intelligent algorithms play a significant role in this paradigm shift, allowing for precision that surpasses manual processes. These algorithms improve the control and monitoring of critical cell therapy procedures, providing consistent and reproducible outcomes. By leveraging advanced automation, the industry is anticipated to meet growing demands while maintaining stringent quality standards, thus propelling the field toward greater accessibility and effectiveness in patient care. Moroever, automated systems play a crucial role in addressing the rising demand for cell therapies due to their unmatched capability to process a significantly higher volume of cells within compressed timeframes. This acceleration in throughput is essential in overcoming the blockage that manual processes often face. By automating critical steps in cell therapy production, such as culturing, harvesting, and quality control checks, these systems amplify overall manufacturing capacity and bolster the industry's ability to swiftly respond to surges in demand. This increased efficiency translates to more patients acquiring access to life-saving and life-improving cell-based treatments, driving this transformative medical technology's advancement and widespread adoption. However, the rapid evolution of automation technology presents a significant challenge for companies in the automated and closed cell therapy market. Those who heavily invest in specific technologies risk facing obsolescence as newer, more advanced solutions emerge. This dynamic necessitates carefully balancing adopting advanced automation and safeguarding against potential technological redundancy. Companies must navigate this landscape with strategic foresight, ensuring that their investments stay adaptable and scalable to accommodate the swiftly evolving landscape of automated systems, further hampering the market growth.

By Workflow

  • Separation
  • Expansion
  • Apheresis
  • Fill – Finish
  • Cryopreservation
  • Others

By Type 

  • Stem Cell Therapy
  • Non- Stem Cell Therapy

By Scale

  • Pre-commercial/R&D Scale
  • Commercial scale

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

(Note: The list of the major players will be updated with the latest market scenario and trends)

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Owing to factors like the increasing prevalence of cancer, the rise in research and development efforts, and the increase in demand for advanced and automated technologies, the market is expected to experience market growth. In addition, technological advancement in integrated intelligent algorithms facilitate high precision, and market players are actively engrossed in the development of infrastructure to exhibit the production of automated systems in the region, is also fueling market expansion. For instance, in June 2021, the collaboration of Lonza and Cell Point announced its plan to use the Cocoon platform to develop T-cell-based therapies. The project is being conducted to deliver a proof of concept for Point-of-Care (POC) production to optimize the supply chain operations. Also, the increasing number of investments and technological adoption for cell therapy processing is further propelling the growth of the market.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Automated And Closed Cell Therapy Market By Workflow, By Type, By Scale and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1. Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3. Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Automated And Closed Cell Therapy Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Automated And Closed Cell Therapy Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Automated And Closed Cell Therapy Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Automated And Closed Cell Therapy Market, By Workflow Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Separation
        2. Expansion
        3. Apheresis
        4. Fill – Finish
        5. Cryopreservation
        6. Others

  • 8.  Automated And Closed Cell Therapy Market, By Type Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Stem Cell Therapy
        2. Non- Stem Cell Therapy

  • 9.  Automated And Closed Cell Therapy Market, By Scale Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Pre-commercial/R&D Scale
        2. Commercial scale

  • 10.  North America Automated And Closed Cell Therapy Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 11.  Latin America Automated And Closed Cell Therapy Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 12.  Europe Automated And Closed Cell Therapy Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 13.  Asia Pacific Automated And Closed Cell Therapy Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 14.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 15.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Thermo Fisher Scientific Inc.
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Miltenyi Biotec GmbH
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. Sartorius AG
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Lonza Group AG
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Terumo BCT, Inc.
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. Fresenius SE & Co. KGaA
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. GE Healthcare
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. Pall Corporation
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. Asahi Kasei Corporation
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. Merck KGaA
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview

  • 17.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.  FutureWise SME Key Takeaway Points for Client
    •    

Partner

Our Clients